HC Agrees to Provide Some Relief Through “Compliance Promotion” Period As has been previously reported, Health Canada (HC) introduced mandatory contact allergen labelling provisions in their Regulatory Amendments to the Cosmetic Regulations […]
CAC has been notified by our Industry Coordinating Group (ICG) for CEPA colleagues that the annual Section 71 Inventory Update Survey will not be released in March or April […]
The Government of Canada has launched a new online reporting platform for the Federal Plastics Registry. This platform offers a secure and user-friendly way to report data. Organizations can […]
March 12, 2025, an order amending the Domestic Substances List (DSL) to vary the requirements under the Significant New Activity (SNAc) provisions for epichlorohydrin (CAS RN 106-89-8) was published […]
March 12, 2025, the Orders and the Regulatory Impact Analysis Statement were published for the accelerated scheduling of fentanyl precursor and carisoprodol to Schedule V of the CDSA. The […]
On March 8, 2025, The Risk Management Approach for 2-mercaptobenzothiazole (MBT) and its precursors, including the substances in the benzothiazoles subgroup and the benzotriazoles subgroup was published. Based on […]
On March 8, 2025, Environment and Climate Change Canada proposed that Boric acid, its salts and its precursors meet the CEPA Section 64 criteria for listing on Schedule 1, […]
On March 8, 2025, Environment and Climate Change Canada proposed that the class of PFAS substances, excluding fluoropolymers, meets the CEPA Section 64 criteria for listing on Schedule 1, […]
On March 3, 2025, Environment and Climate Change Canada released a fact sheet on the use of the moiety approach within the risk assessment process. This approach is used […]
Canada’s Chemicals Management Plan (CMP) program is sharing the following Publications Plan to inform stakeholders of risk management (RM) publications for the coming year. Please note that the targeted […]
